Immediate release tablet cores of insoluble drugs having sustained-release coating

• US 6,024,982 A
• Filed: 06/06/1995
• Issued: 02/15/2000
• Est. Priority Date: 11/23/1993
• Status: Expired due to Term

• Current Assignee: Euroceltique SA
• Original Assignee: Euroceltique SA
• Inventors: Oshlack, Benjamin, Chasin, Mark
• Primary Examiner(s): Page, Thurman K.
• Assistant Examiner(s): Spear, James M.
• Application Number:
  US08/467,575
• Time in Patent Office: 1,715 Days
• Field of Search: 424/468, 424/469, 424/474, 424/479, 424/476, 424/480, 424/482, 424/481, 424/475
• US Class Current: 424/476
• CPC Class Codes: A61K 9/2866 Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

A controlled release tablet for oral administration is disclosed which has a tablet core including an insoluble therapeutically active agent having an aqueous solubility of less than or equal to about 5 mg/ml in a sufficient amount to render a therapeutic effect. The core provides rapid release of said therapeutically active agent upon exposure to aqueous solutions. The tablet core is coated with a controlled release coating permitting sustained release of said therapeutically active agent when said coated tablet is exposed to aqueous solutions.

Claims

1. A method for preparing an oral, sustained release formulation of an insoluble, therapeutically active agent, comprising

coating an immediate release tablet core including acetaminophen in an amount sufficient to render a therapeutic effect with a controlled release coating on the tablet core comprising a hydrophobic material such that said formulation reproducibly provides a dissolution rate in-vitro of the dosage form, when measured by the USP Paddle Method at 100 rpm in 900 ml aqueous buffer, pH between 1.6 and about 7.2, at 37°

C. between 12.5 and 42.5 (by wt) released after 1 hour, between 25 and 56% (by wt) released after 2 hours, between 45 and 75% (by wt) released after 4 hours, and between 55 and 85% (by wt) released after 6 hours.

2. The method of claim 1, further comprising selecting said hydrophobic material from the group consisting of wax, shellac, zein, fatty alcohols, hydrogenated vegetable oils, cellulose derivatives, acrylic polymers, and mixtures of any of the foregoing.

3. The method of claim 2, further comprising coating said tablet core with said hydrophobic material to a weight gain from about 3 to about 20 percent, by weight.

8. The method of claim 1, wherein said tablet releases said acetaminophen over a time period from about 12 to about 24 hours when exposed to fluids in an environment of use.

4. A method of treating a patient with a dose of a pharmaceutical formulation containing acetaminophen over an extended period of time, comprising

preparing an immediate release solid tablet core comprising acetaminophen in an amount sufficient to render a therapeutic effect;

coating said tablet core with a hydrophobic material selected from the group consisting of waxes, shellac, zein, fatty alcohols, hydrogenated vegetable oils, cellulose derivatives, acrylic polymers and mixtures thereof, such that said formulation reproducibly releases acetaminophen at a dissolution rate between 12.5% and 42.5% (by wt) released after 1 hour, between 25% and 56% (by wt) released after 2 hours, between 45% and 75% (by wt) released after 4 hours, between 55% and 85% (by wt) released after 6 hours when measured by the USP Paddle Method at 100 rpm at 900 ml aqueous buffer (pH between 1.6 and 7.2) at 37°

C., and administering said tablet to a patient.

5. The method of claim 4, further comprising incorporating into said tablet an effective amount of a soluble therapeutically active agent selected from the group consisting of hydromorphone, oxycodone, dihydrocodeine, codeine, dihydromorphine, morphine, buprenorphine, salts of any of the foregoing, and mixtures of any of the foregoing.

6. A method for preparing an oral sustained release formulation of acetaminophen, comprising coating an immediate release tablet core including acetaminophen in an amount sufficient to render a therapeutic effect, with a controlled release coating of a hydrophobic material selected from the group consisting of waxes, shellac, zein, fatty alcohols, hydrogenated vegetable oils, cellulose derivatives, acrylic polymers and mixtures thereof, such that said formulation reproducibly provides an in-vitro dissolution rate indicative of a twice-a-day or once-a-day formulation.

7. The method of claim 6, further comprising incorporating into said tablet an effective amount of a soluble therapeutically active agent selected from the group consisting of hydromorphone, oxycodone, dihydrocodeine, codeine, dihydromorphine, morphine, buprenorphine, salts of any of the foregoing, and mixtures of any of the foregoing.